232 related articles for article (PubMed ID: 34940844)
1. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
J Infect Dis; 2022 Apr; 225(7):1118-1123. PubMed ID: 34940844
[TBL] [Abstract][Full Text] [Related]
2. Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion.
Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
medRxiv; 2021 Oct; ():. PubMed ID: 34642697
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
Lee JS; Yun KW; Jeong H; Kim B; Kim MJ; Park JH; Shin HS; Oh HS; Sung H; Song MG; Cho SI; Kim SY; Kang CK; Choe PG; Park WB; Kim NJ; Oh MD; Choi EH; Park S; Kim TS; Lee JH; Sung H; Park SS; Seong MW
Virulence; 2022 Dec; 13(1):1242-1251. PubMed ID: 35891618
[TBL] [Abstract][Full Text] [Related]
4. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.
Ko KKK; Yingtaweesittikul H; Tan TT; Wijaya L; Cao DY; Goh SS; Abdul Rahman NB; Chan KXL; Tay HM; Sim JHC; Chan KS; Oon LLE; Nagarajan N; Suphavilai C
Microbiol Spectr; 2022 Jun; 10(3):e0079122. PubMed ID: 35543562
[TBL] [Abstract][Full Text] [Related]
5. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
Sonnleitner ST; Prelog M; Sonnleitner S; Hinterbichler E; Halbfurter H; Kopecky DBC; Almanzar G; Koblmüller S; Sturmbauer C; Feist L; Horres R; Posch W; Walder G
Nat Commun; 2022 May; 13(1):2560. PubMed ID: 35538074
[TBL] [Abstract][Full Text] [Related]
6. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
[TBL] [Abstract][Full Text] [Related]
7. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.
Weigang S; Fuchs J; Zimmer G; Schnepf D; Kern L; Beer J; Luxenburger H; Ankerhold J; Falcone V; Kemming J; Hofmann M; Thimme R; Neumann-Haefelin C; Ulferts S; Grosse R; Hornuss D; Tanriver Y; Rieg S; Wagner D; Huzly D; Schwemmle M; Panning M; Kochs G
Nat Commun; 2021 Nov; 12(1):6405. PubMed ID: 34737266
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.
Marques AD; Graham-Wooten J; Fitzgerald AS; Sobel Leonard A; Cook EJ; Everett JK; Rodino KG; Moncla LH; Kelly BJ; Collman RG; Bushman FD
mBio; 2024 Mar; 15(3):e0011024. PubMed ID: 38364100
[TBL] [Abstract][Full Text] [Related]
9. Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.
Fournelle D; Mostefai F; Brunet-Ratnasingham E; Poujol R; Grenier JC; Gálvez JH; Pagliuzza A; Levade I; Moreira S; Benlarbi M; Beaudoin-Bussières G; Gendron-Lepage G; Bourassa C; Tauzin A; Grandjean Lapierre S; Chomont N; Finzi A; Kaufmann DE; Craig M; Hussin JG
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543708
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
[TBL] [Abstract][Full Text] [Related]
11. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
[TBL] [Abstract][Full Text] [Related]
12. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
[TBL] [Abstract][Full Text] [Related]
14. De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients.
Simons LM; Ozer EA; Gambut S; Dean TJ; Zhang L; Bhimalli P; Schneider JR; Mamede JI; Ison MG; Karmali R; Gordon LI; Lorenzo-Redondo R; Hultquist JF
Transpl Infect Dis; 2022 Dec; 24(6):e13914. PubMed ID: 35899968
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
Truffot A; Andréani J; Le Maréchal M; Caporossi A; Epaulard O; Germi R; Poignard P; Larrat S
Emerg Infect Dis; 2021 Oct; 27(10):2725-2728. PubMed ID: 34352197
[TBL] [Abstract][Full Text] [Related]
16. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretion.
Andrés C; González-Sánchez A; Jiménez M; Márquez-Algaba E; Piñana M; Fernández-Naval C; Esperalba J; Saubi N; Quer J; Rando-Segura A; Miarons M; Codina MG; Ruiz-Camps I; Pumarola T; Abrisqueta P; Antón A
Clin Microbiol Infect; 2023 Feb; 29(2):240-246. PubMed ID: 36067943
[TBL] [Abstract][Full Text] [Related]
18. Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person.
Munnink BBO; Nijhuis RHT; Worp N; Boter M; Weller B; Verstrepen BE; GeurtsvanKessel C; Corsten MF; Russcher A; Koopmans M
Emerg Infect Dis; 2022 Sep; 28(9):1920-1923. PubMed ID: 35925013
[TBL] [Abstract][Full Text] [Related]
19. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
[TBL] [Abstract][Full Text] [Related]
20. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
